TY - JOUR
T1 - An observational study to validate the Satisfaction Measure of the Injection of Growth Hormone Therapy (SMIGHTy) questionnaire
AU - Rubin, Richard R.
AU - Peyrot, Mark
AU - Metzinger, Catherine P.
AU - Xu, Yaping
AU - Lippe, Barbara
AU - McCormack, Leah
AU - Davis, Daniel Aaron
N1 - Funding Information:
This research was supported by funding from Genentech, which also provided access to the data.
PY - 2011/10
Y1 - 2011/10
N2 - Objective: The objective of this study was to psychometrically evaluate a tool to measure adult caregivers' level of satisfaction with the delivery device used to administer injections of recombinant human growth hormone (rhGH) to a child the Satisfaction Measure of the Injection of Growth Hormone Therapy (SMIGHTy*) questionnaire. Research design and methods: One hundred caregivers who administer rhGH to a child using an injection device completed the SMIGHTy questionnaire at baseline and 714 days later, and also completed other measures of treatment adherence and treatment satisfaction at baseline. Main outcome measures: SMIGHTy reliability (inter-item and testretest) and external validity (association with other study measures) were assessed. Results: Analyses revealed good inter-item agreement and testretest reliability for the SMIGHTy questionnaire. External validity, measured by associations with adherence and other measures of treatment satisfaction, was high. Study limitations: This study assessed only adult caregivers; the instrument was not validated for use by young or adult patients. Conclusions: The SMIGHTy instrument is more comprehensive than existing instruments for assessing the growth hormone treatment experience. It is multidimensional, assesses both positive and negative aspects of the treatment experience (Device Satisfaction, Negative Events, Benefits), and has separate measures of overall satisfaction and preference.
AB - Objective: The objective of this study was to psychometrically evaluate a tool to measure adult caregivers' level of satisfaction with the delivery device used to administer injections of recombinant human growth hormone (rhGH) to a child the Satisfaction Measure of the Injection of Growth Hormone Therapy (SMIGHTy*) questionnaire. Research design and methods: One hundred caregivers who administer rhGH to a child using an injection device completed the SMIGHTy questionnaire at baseline and 714 days later, and also completed other measures of treatment adherence and treatment satisfaction at baseline. Main outcome measures: SMIGHTy reliability (inter-item and testretest) and external validity (association with other study measures) were assessed. Results: Analyses revealed good inter-item agreement and testretest reliability for the SMIGHTy questionnaire. External validity, measured by associations with adherence and other measures of treatment satisfaction, was high. Study limitations: This study assessed only adult caregivers; the instrument was not validated for use by young or adult patients. Conclusions: The SMIGHTy instrument is more comprehensive than existing instruments for assessing the growth hormone treatment experience. It is multidimensional, assesses both positive and negative aspects of the treatment experience (Device Satisfaction, Negative Events, Benefits), and has separate measures of overall satisfaction and preference.
KW - Injectable human growth hormone
KW - Patient satisfaction
KW - Self-report
KW - Validity
UR - http://www.scopus.com/inward/record.url?scp=80053013754&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80053013754&partnerID=8YFLogxK
U2 - 10.1185/03007995.2011.613922
DO - 10.1185/03007995.2011.613922
M3 - Article
C2 - 21919819
AN - SCOPUS:80053013754
SN - 0300-7995
VL - 27
SP - 2009
EP - 2017
JO - Current Medical Research and Opinion
JF - Current Medical Research and Opinion
IS - 10
ER -